Clues on antipsychotic drugs side effects offer hope
5 July 2011
Weight-gain and diabetes-like symptoms are common side effects of antipsychotic medications, and New Zealand research into the chemical changes involved is raising hope that these effects may be better managed or eliminated.
New Zealand cancer drug to commence clinical trials
13 June 2011
A novel cancer drug designed by scientists from The University of Auckland and Maurice Wilkins Centre for Molecular Biodiscovery, and licensed to university spin-out company Pathway Therapeutics, Inc., has received approval from the US Food and Drug Administration to enter c...
New Zealand-designed anti-tumour agent to enter clinical development
7 June 2011
A novel anti-tumour agent, CEN-209, created by New Zealand scientists will enter clinical development under two international agreements announced last week.
Founding Chair named Fellow of The University of Auckland
29 April 2011
William Falconer CNZM LL.B. has been named a Fellow of The University of Auckland. The honour, conferred during Autumn Graduation, recognises his outstanding contribution to the University as Founding Chair of the Board of the Maurice Wilkins Centre for Molecular Biodiscover...